Clinical Studies

•Clinical Study Shows One Of Our Key Ingredients Beat Prescription

Peyronie’s Medication Dramatically (Proof Below)



(These Ingredients found In Our Complete Peyronie’s Health Package)Peyronies Treatment 2014

Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie’s disease: a preliminary report



To detect whether oral acetyl-L-carnitine might be useful in the acute and early chronic phases of Peyronie’s disease, compared with tamoxifen, a drug currently in use.


The study included 48 patients with Peyronie’s disease (15 acute and 33 initial chronic), randomized equally into two
groups. The first group used tamoxifen 20 mg twice daily for 3-months and the second acetyl-L-carnitine 1-g  twice daily for 3-months. The disease and stages were diagnosed and identified using a history, objective examination, pharmacologically induced erection, autophotography during erection, and basic and dynamic colour Doppler ultrasonography. Penile curvature, plaque size, pain and disease progression were assessed. The differences between the groups or between the variables before and after therapy were compared using analysis of variance or the chi-squared test.


Acetyl-L-carnitine was significantly more effective than tamoxifen in reducing pain and in inhibiting disease progression. Acetyl-L-carnitine reduced penile curvature significantly, while tamoxifen did not; both drugs significantly reduced plaque size. Tamoxifen induced significantly more side-effects than acetyl-L-carnitine.


These results suggest that acetyl-L-carnitine is significantly more effective and safe than tamoxifen in the therapy of acute and early chronic Peyronie’s disease.

Actual Link to Test Data: Click Here

Source: United States Library of Medicine National Institutes For Health


•Differential Approach To The Use of Drug ‘Ultraphonophoresis’ For Scars

(Another Ingredient Also Found in Our Complete Peyronies Health Package)


A differential approach to administration of drug ultraphonophoresis (gel contractubex, collitin, elastolitin) in scarry Peyrones Disease Treatmentdeformations is proposed. The analysis of 82 treatment outcomes has shown that early after trauma (on day 6-12) it is more beneficial to use ultraphonophoresis (UPP) of heparin-containing compounds improving blood rheology, e.g. lidase. This prevents development of pathological scars. Later, when the scar tissues has already formed, more effective is UPP of enzyme medicines with fibrinolytic properties (collitin, elastolitin). Differentiated choice of UPP in scar therapy reduces the time of rehabilitation considerably.

Actual Link to Test Data: Click Here

Source: United States Library of Medicine National Institutes For Health


•New Studies Prove Vitamin D Has Been Highly Under Rated Until Very


(Our Cholecal-10 is A unique, high dosage of pure liquid gel Cholecalciferol, the most powerful Vitamin D concentrate on earth)

2010 Feb;95(2):471-8. doi: 10.1210/jc.2009-1773

Update in Vitamin D


UCLA-Orthopaedic Hospital Research Center, 615 Charles Young Drive South, Room 410E, Los Angeles, California 90095-7358, USA


The past decade, particularly the last 18 months, witnessed a vigorous increase in interest in vitamin D from both the lay Enzymex Peyroniesand biomedical worlds. Much of the growing interest in vitamin D is powered by new data being extracted from the National Health and Nutrition Examination Survey (NHANES). The newest statistics demonstrate that more than 90% of the pigmented populace of the United States (Blacks, Hispanics, and Asians) now suffer from vitamin D insufficiency (25-hydroxyvitamin D <30 ng/ml), with nearly three fourths of the white population in this country also being vitamin D insufficient. This represents a near doubling of the prevalence of vitamin D insufficiency seen just 10-yr ago in the same population. This review attempts to provide some explanation for: 1) the rapid decline in vitamin D status in the United States; 2) the adverse impact of vitamin D insufficiency on skeletal, infectious/inflammatory, and metabolic health in humans; and 3) the therapeutic rationale and reliable means for vigorous supplementation of our diets with vitamin D.

Actual Link to Test Data: Click Here

Source: United States Library of Medicine National Institutes For Health


Vitamin D has more important functions beyond those of calcium and bone homeostasis which include modulation of the innate and adaptive immune responses as once thought. Vitamin D deficiency is prevalent in autoimmune disease. Cells of the immune system are capable of synthesizing and responding to vitamin D. Immune cells in autoimmune diseases are responsive to the ameliorative effects of vitamin D suggesting that the beneficial effects of supplementing vitamin D deficient individuals with autoimmune disease may extend beyond effects on bone and calcium homeostasis. Vitamin D is a critical supplement for immune health.



•Dr. James Howenstine On Enzyme Therapy For Dissolving Scar Tissue

(Another Ingredient Found In Our Complete Peyronie’s Health Package)

Bent Penis Treatment “Enzyme therapy is a prime example of a situation in which US medicine is missing the boat due to a lack of awareness of what the rest of the world is doing and our unwillingness to use therapies not made by “big pharma.” Enzymes can not be patented so they are of little interest to drug companies.

The proteolytic enzymes used in enzyme therapy dissolve fibrin (Scar tissue). When strong proteolytic enzymes are in an enzyme preparation, they can be powerful enough in their action to actually gradually digest scar tissue away. This takes time to occur, of course, but eventually all the scar tissue can fully disappear. “

Source: Dr. James Howenstine, News Website


Ready To Start Your
Peyronie’s Correction Regimen?

peyrones disease